Story perspectives
New Study Uncovers Link Between APOL1 Mutations and Kidney Disease
10/4/2025
50 7
1 of 1
Story summary
- APOL1 mutations impair mitochondrial function in podocytes, driving APOL1-mediated kidney disease (AMKD).
- CKD affects 700 million; APOL1 mutations are common in West Africans.
- Researchers at the University of Leiden used induced pluripotent stem cells from APOL1 mutation carriers to model AMKD.
- Inflammatory stress worsens mitochondrial dysfunction, linked to AMKD.
- The study aims to deepen understanding and accelerate drug discovery.
